Amgen launches an AbbVie Humira biosimilar in the US
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- Nasdaq futures slide as AI warnings rattle markets; Nvidia, other chip stocks retreat
- Global AI stocks fall as industry chiefs call for slowing development
- Oil prices continue surge, rising 3% as attacks halt Saudi pipeline
- BofA sees just 2% upside for the S&P 500 over the next 12 months
- Wall Street's new pair trade: Long software, short chips
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Amgen (AMGN) Announces Amjevita now Available in the US
January 31, 2023 6:03 AM ESTAmgen (NASDAQ: AMGN) today announced AMJEVITA (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the United States. AMJEVITA was the first biosimilar to Humira approved by the U.S. Food and Drug Administration (FDA), in 2016.2,3
"With today's announcement, AMJEVITA is the first U.S. biosimilar to Humira®, a medicine used by more than a million patients living with certain serious inflammatory diseases," said Murdo... More
Amgen (AMGN) PT Lowered to $260 at UBS
January 30, 2023 8:51 AM ESTUBS analyst Colin Bristow lowered the price target on Amgen (NASDAQ: AMGN) to $260.00 (from $271.00) while maintaining a Neutral rating.... More
Drugmaker Amgen lays off 300 U.S. employees
January 30, 2023 7:56 AM EST(Reuters) -Drugmaker Amgen Inc said on Monday that it let go about 300 U.S. employees or about 1.2% of its total workforce, citing recent organizational changes to its commercial team.
The company had about 24,200 staff members in over 50 countries, as of December 31, 2021, according to its latest annual regulatory... More
